Rapid progression of coronary artery disease in a patient with retroperitoneal fibrosis

Kotaro Oe1, Tsutomu Araki1, Tetsuo Konno2

  • 1Division of Internal Medicine, Saiseikai Kanazawa Hospital, Kanazawa, Japan.

Journal of Cardiology Cases
|December 15, 2018
PubMed

Insights

A patient experienced worsening coronary artery disease and retroperitoneal fibrosis after stenting. Corticosteroid therapy stabilized the coronary lesions, suggesting a potential link between arteritis and these conditions.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Inflammatory Diseases

Background:

  • A 76-year-old woman with hypertension and dyslipidemia presented with acute anterior myocardial infarction.
  • Initial coronary angiography revealed left anterior descending (LAD) and left circumflex (LCX) artery occlusions, treated with a paclitaxel-eluting stent in the LAD.

Observation:

  • Two weeks post-stenting, the patient developed abdominal pain, with CT and FDG-PET/CT scans indicating perivascular cuffing and increased uptake around the abdominal aorta, suggestive of retroperitoneal fibrosis.
  • Serial coronary angiographies demonstrated rapid progression of coronary artery lesions, including new occlusions and stenosis, particularly in the LCX artery and its branches, as well as the posterior descending artery.

Findings:

  • The patient was diagnosed with suspected coronary arteritis and initiated on oral corticosteroid therapy.
  • Following corticosteroid treatment, a repeat coronary angiography performed five months later showed no further progression of coronary lesions.

Implications:

  • This case highlights a potential association between coronary arteritis, retroperitoneal fibrosis, and stent placement.
  • Corticosteroid therapy may be effective in managing rapidly progressing coronary artery lesions in the context of suspected arteritis.
  • Further research is warranted to elucidate the underlying mechanisms and optimal management strategies for such complex vascular inflammatory conditions.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
443
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
267
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
372
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
687
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
378